Evidence map›Paper›PMID 35040158›Full record

ArticlePlant, cell & environment2022

Nuclear and peroxisomal targeting of catalase.

Yousef Al-Hajaya, Barbara Karpinska, Christine H Foyer, Alison Baker

Open access · hybridAbstract read
In one paragraph

Article in Plant, cell & environment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Nuclear and peroxisomal targeting of catalase.Plant, cell & environment · 2022
    Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yousef Al-HajayaCentre for Plant Sciences and School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
Barbara KarpinskaCentre for Plant Sciences and School of Biology, University of Leeds, Leeds, UK.
Christine H FoyerCentre for Plant Sciences and School of Biology, University of Leeds, Leeds, UK.ORCID 0000-0001-5989-6989
Alison BakerCentre for Plant Sciences and School of Molecular and Cellular Biology, University of Leeds, Leeds, UK.ORCID 0000-0003-2181-4057
University of Leeds · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Catalase is a well-known component of the cellular antioxidant network, but there have been conflicting conclusions reached regarding the nature of its peroxisome targeting signal. It has also been reported that catalase can be hijacked to the nucleus by effector proteins of plant pathogens. Using a physiologically relevant system where native untagged catalase variants are expressed in a cat2-1 mutant background, the C terminal most 18 amino acids could be deleted without affecting activity, peroxisomal targeting or ability to complement multiple phenotypes of the cat2-1 mutant. In contrast, converting the native C terminal tripeptide PSI to the canonical PTS1 sequence ARL resulted in lower catalase specific activity. Localisation experiments using split superfolder green fluorescent protein revealed that catalase can be targeted to the nucleus in the absence of any pathogen effectors, and that C terminal tagging in combination with alterations of the native C terminus can interfere with nuclear localisation. These findings provide fundamental new insights into catalase targeting and pave the way for exploration of the mechanism of catalase targeting to the nucleus and its role in non-infected plants.

Indexed as

PeroxisomesReceptors, Cytoplasmic and NuclearCatalaseGreen Fluorescent ProteinsPeroxisome-Targeting Signal 1 ReceptorCatalaseGreen Fluorescent ProteinsPeroxisome-Targeting Signal 1 ReceptorReceptors, Cytoplasmic and Nuclearnucleusperoxisomeredox signallingROS

Identifiers

PMID35040158
PMCPMC9305541
OpenAlexW4205126197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.